134 related articles for article (PubMed ID: 36436338)
1. De novo design of dual-target JAK2, SMO inhibitors based on deep reinforcement learning, molecular docking and molecular dynamics simulations.
He L; Liu J; Zhao HL; Zhang LC; Yu RL; Kang CM
Biochem Biophys Res Commun; 2023 Jan; 638():23-27. PubMed ID: 36436338
[TBL] [Abstract][Full Text] [Related]
2. Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
Doheny D; Sirkisoon S; Carpenter RL; Aguayo NR; Regua AT; Anguelov M; Manore SG; Arrigo A; Jalboush SA; Wong GL; Yu Y; Wagner CJ; Chan M; Ruiz J; Thomas A; Strowd R; Lin J; Lo HW
Oncogene; 2020 Oct; 39(42):6589-6605. PubMed ID: 32929154
[TBL] [Abstract][Full Text] [Related]
3. Blockade of PDGFRβ circumvents resistance to MEK-JAK inhibition via intratumoral CD8
Kalimutho M; Sinha D; Mittal D; Srihari S; Nanayakkara D; Shafique S; Raninga P; Nag P; Parsons K; Khanna KK
J Exp Clin Cancer Res; 2019 Feb; 38(1):85. PubMed ID: 30777101
[TBL] [Abstract][Full Text] [Related]
4. Machine Learning-Based Drug Repositioning of Novel Janus Kinase 2 Inhibitors Utilizing Molecular Docking and Molecular Dynamic Simulation.
Yasir M; Park J; Han ET; Park WS; Han JH; Kwon YS; Lee HJ; Chun W
J Chem Inf Model; 2023 Nov; 63(21):6487-6500. PubMed ID: 37906702
[TBL] [Abstract][Full Text] [Related]
5. Discovery of [1,2,4]triazolo[4,3-a]pyridines as potent Smoothened inhibitors targeting the Hedgehog pathway with improved antitumor activity in vivo.
Tian N; Wu H; Zhang H; Yang D; Lv L; Yang Z; Zhang T; Quan D; Zhou L; Xie Y; Xu Y; Wei N; Zhang J; Chen M; Schmitz JC; Tian Y; Wu S
Bioorg Med Chem; 2020 Aug; 28(16):115584. PubMed ID: 32690258
[TBL] [Abstract][Full Text] [Related]
6. Ligand-based 3D pharmacophore modeling, virtual screening, and molecular dynamic simulation of potential smoothened inhibitors.
Mohebbi A
J Mol Model; 2023 Apr; 29(5):143. PubMed ID: 37062794
[TBL] [Abstract][Full Text] [Related]
7. Integrated virtual screening and molecular dynamics simulation approaches revealed potential natural inhibitors for DNMT1 as therapeutic solution for triple negative breast cancer.
Bashir Y; Noor F; Ahmad S; Tariq MH; Qasim M; Tahir Ul Qamar M; Almatroudi A; Allemailem KS; Alrumaihi F; Alshehri FF
J Biomol Struct Dyn; 2024; 42(3):1099-1109. PubMed ID: 37021492
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel inhibitors from Urtica spp against TNBC targeting JAK2 receptor for breast cancer therapy.
Upreti S; Muduli K; Pradhan J; Elangovan S; Samant M
Med Oncol; 2023 Oct; 40(11):326. PubMed ID: 37806999
[TBL] [Abstract][Full Text] [Related]
9. JAK2 regulates paclitaxel resistance in triple negative breast cancers.
Han J; Yun J; Quan M; Kang W; Jung JG; Heo W; Li S; Lee KJ; Son HY; Kim JH; Choi J; Noh DY; Na D; Ryu HS; Lee C; Kim JI; Moon HG
J Mol Med (Berl); 2021 Dec; 99(12):1783-1795. PubMed ID: 34626199
[TBL] [Abstract][Full Text] [Related]
10. Deciphering structural stability and binding mechanisms of potential antagonists with smoothened protein.
Sinha N; Chowdhury S; Sarkar RR
J Biomol Struct Dyn; 2018 Aug; 36(11):2917-2937. PubMed ID: 28849750
[TBL] [Abstract][Full Text] [Related]
11. Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer.
Chen KC; Sun MF; Chen HY; Lee CC; Chen CY
Biomed Res Int; 2014; 2014():873010. PubMed ID: 25136636
[TBL] [Abstract][Full Text] [Related]
12. Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer.
Mumin NH; Drobnitzky N; Patel A; Lourenco LM; Cahill FF; Jiang Y; Kong A; Ryan AJ
BMC Cancer; 2019 Jan; 19(1):102. PubMed ID: 30678647
[TBL] [Abstract][Full Text] [Related]
13. Analogs of cinnamic acid benzyl amide as nonclassical inhibitors of activated JAK2 kinase.
Mielecki M; Milner-Krawczyk M; Grzelak K; Mielecki D; Krzysko KA; Lesyng B; Priebe W
Curr Cancer Drug Targets; 2014; 14(7):638-51. PubMed ID: 25146330
[TBL] [Abstract][Full Text] [Related]
14. Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence.
Balko JM; Schwarz LJ; Luo N; Estrada MV; Giltnane JM; Dávila-González D; Wang K; Sánchez V; Dean PT; Combs SE; Hicks D; Pinto JA; Landis MD; Doimi FD; Yelensky R; Miller VA; Stephens PJ; Rimm DL; Gómez H; Chang JC; Sanders ME; Cook RS; Arteaga CL
Sci Transl Med; 2016 Apr; 8(334):334ra53. PubMed ID: 27075627
[TBL] [Abstract][Full Text] [Related]
15. A computationally affordable approach for accurate prediction of the binding affinity of JAK2 inhibitors.
Mai NT; Lan NT; Vu TY; Tung NT; Phung HTT
J Mol Model; 2022 May; 28(6):163. PubMed ID: 35599265
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel 4-aminopiperidine derivatives as SMO/ERK dual inhibitors.
Zhang JJ; Zhang W; Zhang L; Hu M; Xu QJ; Xu Y
Bioorg Med Chem; 2022 Nov; 74():117051. PubMed ID: 36270113
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibitors of Janus kinase 2 and 3 (JAK2/3): designing by pharmacophore- and docking-based virtual screening approach.
Jasuja H; Chadha N; Kaur M; Silakari O
Mol Divers; 2014 May; 18(2):253-67. PubMed ID: 24415188
[TBL] [Abstract][Full Text] [Related]
18. Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation.
Yasir M; Park J; Han ET; Park WS; Han JH; Chun W
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542998
[TBL] [Abstract][Full Text] [Related]
19. Piperlongumine Induces Apoptosis and Synergizes with Doxorubicin by Inhibiting the JAK2-STAT3 Pathway in Triple-Negative Breast Cancer.
Chen D; Ma Y; Li P; Liu M; Fang Y; Zhang J; Zhang B; Hui Y; Yin Y
Molecules; 2019 Jun; 24(12):. PubMed ID: 31242627
[TBL] [Abstract][Full Text] [Related]
20. Triazoles bind the C-terminal domain of SMO: Illustration by docking and molecular dynamics simulations the binding between SMO and triazoles.
Liu M; Liang G; Zheng H; Zheng N; Ge H; Liu W
Life Sci; 2019 Jan; 217():222-228. PubMed ID: 30543826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
